Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
Cancer Biology & Therapy
|
March 26, 2015
Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation
Avisnata Das, Miriam Kunkel, Jamal Joudeh, et al.
Cancer Research
|
February 15, 2015
Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10
Joshua E Allen, Varun V Prabhu, Mala Talekar, et al.
Cancer Biology & Therapy
|
July 5, 2011
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents
Wenge Wang, Jean-Nicolas Gallant, Sharyn I Katz, et al.
Cancer Cell
|
December 21, 2004
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
Peiwen Fei, Wenge Wang, Seok-hyun Kim, et al.
Cancer Biology & Therapy
|
October 25, 2013
Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients
Jussuf T Kaifi, Miriam Kunkel, Junjia Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2011
Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting
Bishoy Faltas, Amer Zeidan, Kristi Peters, et al.
Cancer Cell
|
February 11, 2026
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
Peiwen Fei, Wenge Wang, Seok-Hyun Kim, et al.
Cancer Research
|
August 22, 2015
Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
Shengliang Zhang, Lanlan Zhou, Bo Hong, et al.
Cancer Research
|
March 16, 2026
Editor's Note: Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
Shengliang Zhang, Lanlan Zhou, Bo Hong, et al.
Oncotarget
|
November 16, 2017
Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP
Avital Lev, Amriti R Lulla, Jessica Wagner, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
Cancer Biology & Therapy
|
March 26, 2015
Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation
Avisnata Das, Miriam Kunkel, Jamal Joudeh, et al.
Cancer Research
|
February 15, 2015
Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10
Joshua E Allen, Varun V Prabhu, Mala Talekar, et al.
Cancer Biology & Therapy
|
July 5, 2011
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents
Wenge Wang, Jean-Nicolas Gallant, Sharyn I Katz, et al.
Cancer Cell
|
December 21, 2004
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
Peiwen Fei, Wenge Wang, Seok-hyun Kim, et al.
Cancer Biology & Therapy
|
October 25, 2013
Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients
Jussuf T Kaifi, Miriam Kunkel, Junjia Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2011
Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting
Bishoy Faltas, Amer Zeidan, Kristi Peters, et al.
Cancer Cell
|
February 11, 2026
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
Peiwen Fei, Wenge Wang, Seok-Hyun Kim, et al.
Cancer Research
|
August 22, 2015
Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
Shengliang Zhang, Lanlan Zhou, Bo Hong, et al.
Cancer Research
|
March 16, 2026
Editor's Note: Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
Shengliang Zhang, Lanlan Zhou, Bo Hong, et al.
Oncotarget
|
November 16, 2017
Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP
Avital Lev, Amriti R Lulla, Jessica Wagner, et al.
Page
of 10